CME/CE from MPR


MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for myCME.com. See below for a list of each quarter's courses. Click here to visit MPR's website.




Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits
HM 


MPR Drug News


Heart Rate May Be an Indicator of Future Diabetes Risk

Heart rate measures may help identify a person's future risk of diabetes, researchers have proposed.

Can a Drug Used to Treat Stroke Be Effective for Otitis Media?

A drug to treat stroke showed efficacy in treating middle-ear infections by suppressing mucus overproduction, improving bacterial clearance, and reducing hearing loss, researchers from the Georgia State University and University of Rochester reported.

New ADHD Treatment Coming Soon

Aptensio XR (methylphenidate HCl extended-release) capsules will be available starting Summer 2015 for the treatment of attention deficit hyperactivity disorder (ADHD).

New Centrum MultiGummies Launched

Pfizer Consumer Healthcare announced the launch of Centrum MultiGummies, a multivitamin to help support energy, immunity, and metabolism.

Combination COPD Therapy Improves Lung Function in Trials

Boehringer Ingelheim announced new data analyses from the Phase 3 TONADO 1&2 studies of tiotropium/olodaterol delivered via Respimat inhaler for chronic obstructive pulmonary disease (COPD).